We next sought to investigate whether total levels of N368-cleaved Tau increase during the development of Tau pathology in two transgenic mouse models of tauopathy, the Thy1.P301Stau [1] and the rTg4510 [23] mice. The gene discussed is MAPT; the disease is tauopathy.